Nonimmunologic adverse drug reactions

Preview

How can morbidity and mortality from adverse drug reactions be reduced and associated costs be minimized? What predictable reactions are commonly encountered in primary care? What should you watch for in terms of unpredictable reactions in susceptible patients? Dr Bernstein answers these and other questions and outlines a system for classifying adverse drug reactions.

Additional information

Notes on contributors

Jonathan A. Bernstein

Jonathan A. Bernstein, MD Dr Bernstein is assistant professor, division of immunology, department of internal medicine, and codirector, allergy training program, University of Cincinnati College of Medicine. His research interests include occupational asthma, the role of T-cell receptors in asthma, seminal plasma protein allergy, and drug reactions. He is also active in teaching and patient care.